Colgate-Palmolive Company CL delivered mixed results for fourth-quarter 2024. While the company's earnings exceeded the Zacks Consensus Estimate, its revenues fell short of expectations. Despite the ...

Growing concerns over incoming tariffs and inflation are driving heightened uncertainty among U.S. consumers. As a defensive ...

Argus lowered the firm’s price target on Colgate-Palmolive (CL) to $104 from $112 but keeps a Buy rating on the shares. The firm has a ...

We recently published a list of 12 Best FMCG Stocks To Buy According to Hedge Funds. In this article, we are going to take a ...

In August, Musk doubled down by suing Unilever, Mars, CVS Health and several other companies that had dropped Twitter, ...

We recently published a list of 12 Best Beauty Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.

In a report released on February 1, Andrea Faria Teixeira from J.P. Morgan maintained a Buy rating on Colgate-Palmolive (CL – Research Report), ...

That premium sets a high bar for management in the February earnings announcement. If you're risk-averse, then you could wait ...